Mahmoud Al-Hawary, MD, discusses the current NCCN guidelines for imaging and how they play a role in patients with pancreatic cancer.
Mahmoud Al-Hawary, MD, associate professor, Radiology, University of Michigan Health System, discusses the current NCCN guidelines for imaging and how they play a role in patients with pancreatic cancer. Al-Hawary says this imaging is important because it gives doctors complete information they would need to know for staging, diagnosis, and treatment of their patient's disease.
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More